Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Uriach is a prominent European consumer healthcare company with a legacy dating back to 1838, making it one of the oldest pharmaceutical entities in the region. Headquartered in Spain, the company has recently undergone a strategic pivot to focus exclusively on Natural Consumer Healthcare, divesting its traditional generic medicine and API manufacturing divisions in 2021. Its portfolio is centered on well-known brands such as Aquilea, Fisiocrem, Biodramina, and Aerored, covering therapeutic areas like sleep, pain relief, and digestive health. Uriach maintains a strong international footprint with a direct presence in several European markets including Italy, Germany, and Portugal. The company combines pharmaceutical rigor with a focus on natural ingredients to lead the market in food supplements and over-the-counter solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on J. Uriach.